The Point of View Award, which includes a $10,000 honorarium, recognizes an outstanding scholarly article published in a high-impact peer-reviewed journal during the previous calendar year related to efforts to restore vision through regenerative ophthalmology, biotechnology, whole eye transplantation or other approaches to the stated problem.

The intent of the Point of View Award is to recognize and incentivize significant research that may advance the ability to restore sight to those who are blind or have significant visual impairment. The award was established in 2020 and the first award was given in 2021.

Applications open Aug. 1 - Oct. 1

View eligibility details and how to apply

2022 recipient

Tasneem Khatib, DM, FRCOphth
Article title: Receptor-ligand replacement via a self-cleaving 2A peptide-based gene therapy promotes CNS axonal transport with functional recovery; Science Advances - March 31, 2021
(Corresponding author: Keith Martin, MA, DM, MRCP, FRCOphth, FRANZCO, FARVO)

2021 recipients

Dasha Nelidova, MBChB, PhD
Botond Roska, MD, PhD